# ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)

> **NCT05135403** · — · RECRUITING · sponsor: **Kestra Medical Technologies, Inc.** · enrollment: 5179 (estimated)

## Conditions studied

- Sudden Cardiac Arrest

## Interventions

- **DEVICE:** Defibrillation

## Key facts

- **NCT ID:** NCT05135403
- **Lead sponsor:** Kestra Medical Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-20
- **Primary completion:** 2025-10-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 5179 (ESTIMATED)
- **Last updated:** 2025-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05135403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05135403, "ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05135403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*